FLUOROPOLYMER COMPOSITIONS AND METHOD OF USE
    415.
    发明申请
    FLUOROPOLYMER COMPOSITIONS AND METHOD OF USE 审中-公开
    氟聚合物组合物和使用方法

    公开(公告)号:US20110178260A1

    公开(公告)日:2011-07-21

    申请号:US12690674

    申请日:2010-01-20

    Abstract: A composition comprising monomers copolymerized in the following percentages by weight: (a) from about 20% to about 95% of a monomer, or mixture of monomers, of formula (I): Rf—(CH2CF2)q(CH2CH2)r—Z—C(O)—C(R)═CH2  (I) wherein q and r are each independently integers of 1 to 3; Rf is a linear or branched perfluoroalkyl group having 2 to 6 carbon atoms; Z is —O—, —NR1— or —S—; R is hydrogen, Cl, F or CH3; R1 is hydrogen, or a C1 to C4 alkyl; and (b) from about 5% to about 80% of at least one of: (i) an alkyl (meth)acrylate monomer having a linear, branched or cyclic alkyl group of 6 to 18 carbons; or (ii) a monomer of formula (II): (R2)2N—R3—O—C(O)—C(R)═CH2  (II) wherein R is as defined above; each R2 is independently a C1 to C4 alkyl; and R3 is a divalent linear or branched C1 to C4 alkylene; and wherein the nitrogen is from about 40% to 100% salinized; or (iii) a mixture thereof; said composition providing oil repellency, water repellency, and stain resistance to substrates contacted therewith; and a method for treating substrates with such copolymer compositions; are disclosed.

    Abstract translation: 包含按以下重量百分比共聚单体的组合物:(a)约20%至约95%的式(I)单体或单体混合物:Rf-(CH 2 CF 2)q(CH 2 CH 2)r-Z -C(O)-C(R)= CH 2(I)其中q和r各自独立地为1至3的整数; Rf是具有2-6个碳原子的直链或支链全氟烷基; Z是-O-,-NR1-或-S-; R是氢,Cl,F或CH 3; R1是氢或C1-C4烷基; 和(b)约5%至约80%的至少一种:(i)具有6至18个碳原子的直链,支链或环状烷基的(甲基)丙烯酸烷基酯单体; 或(ii)式(II)的单体:(R2)2N-R3-O-C(O)-C(R)= CH2(Ⅱ)其中R定义同上; 每个R 2独立地为C 1至C 4烷基; 并且R 3是二价直链或支链C1至C4亚烷基; 并且其中所述氮为约40%至100%盐碱化; 或(iii)其混合物; 所述组合物对与其接触的基材提供拒油性,拒水性和耐污染性; 和用这种共聚物组合物处理底物的方法; 被披露。

    Method of authentication in IP multimedia subsystem
    416.
    发明授权
    Method of authentication in IP multimedia subsystem 有权
    IP多媒体子系统认证方法

    公开(公告)号:US07974604B2

    公开(公告)日:2011-07-05

    申请号:US11842668

    申请日:2007-08-21

    CPC classification number: H04L63/20 H04L63/08 H04L63/205 H04L65/1016

    Abstract: A method of authentication in an IMS includes: after receiving a Register message from a UE, locating, by a P-CSCF, a CLF according to information contained in the Register message and a pre-configured relationship; querying, by the P-CSCF, the CLF about NASS attachment information of the UE to obtain a query result, and sending the Register message carrying the query result to an I-CSCF; forwarding, by the I-CSCF, the Register message carrying the query result to a S-CSCF assigned by a UPSF or the HSS; authenticating the UE and sending an authentication result to the UE by the S-CSCF. In embodiments of the present invention, the UPSF or the HSS in the service layer determines the authentication mechanism of the user, and the S-CSCF implements the authentication, which is more reasonable. Embodiments of the present invention also provide combinations of NBA with other authentication mechanisms, thereby guarantees the authentication of the user after the NBA authentication fails.

    Abstract translation: IMS中的认证方法包括:在接收到来自UE的注册消息之后,根据包含在所述注册消息中的信息和预先配置的关系,由P-CSCF定位CLF; 由P-CSCF询问CLF关于UE的NASS附件信息以获得查询结果,并将携带查询结果的Register消息发送到I-CSCF; 由I-CSCF将携带查询结果的注册消息转发给由UPSF或HSS分配的S-CSCF; 认证UE并通过S-CSCF向UE发送认证结果。 在本发明的实施例中,服务层中的UPSF或HSS确​​定用户的认证机制,并且S-CSCF执行认证,这更为合理。 本发明的实施例还提供NBA与其他认证机制的组合,从而保证在NBA认证失败之后用户的认证。

    CERTAIN CRYSTALLINE HYDRATES, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHODS FOR PREPARATION AND USE THEREOF
    418.
    发明申请
    CERTAIN CRYSTALLINE HYDRATES, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHODS FOR PREPARATION AND USE THEREOF 有权
    某些晶体水合物,其药物组合物及其制备和使用方法

    公开(公告)号:US20110136822A1

    公开(公告)日:2011-06-09

    申请号:US12938555

    申请日:2010-11-03

    Applicant: Feng Que Ying Wang

    Inventor: Feng Que Ying Wang

    CPC classification number: C07D263/22 A61K31/496

    Abstract: At least one crystalline hydrate of (S)—[N-3-(3′-fluoro-4′-(4″-phenyl piperazinyl))phenyl-2-oxo-5-oxazolidinyl]methyl acetamide, such as those with the following formula: wherein y is a number ranging from 1/12 to 1. Also provided are methods for the preparation of such crystalline hydrates, pharmaceutical compositions comprising such crystalline hydrates, and methods for their uses.

    Abstract translation: (S) - [N-3-(3'-氟-4' - (4“ - 苯基哌嗪基))苯基-2-氧代-5-恶唑烷基]甲基乙酰胺的至少一种结晶水合物, 下式:其中y是范围从1/12至1的数字。还提供了制备这种结晶水合物的方法,包含这种结晶水合物的药物组合物,及其用途的方法。

    MICROHOLE-STRUCTURED LONG PERIOD FIBER GRATING
    419.
    发明申请
    MICROHOLE-STRUCTURED LONG PERIOD FIBER GRATING 有权
    MICROHOLE-STRUCTURED长期光纤光栅

    公开(公告)号:US20110135245A1

    公开(公告)日:2011-06-09

    申请号:US12633782

    申请日:2009-12-08

    Abstract: An optical fiber with long period fiber gratings includes an optical fiber axis, a core region extending along the fiber axis, the core region having a core refractive index, a cladding region surrounding the core region, the cladding having a cladding refractive index, and a plurality of microholes perpendicular to the fiber axis with a portion of the core region removed, the plurality of microholes are spaced apart by a grating period.

    Abstract translation: 具有长周期光纤光栅的光纤包括光纤轴,沿着光纤轴延伸的芯区域,具有芯折射率的芯区域,围绕芯区域的包层区域,包层具有包层折射率,以及 多个微孔与纤维轴垂直,芯区的一部分被去除,多个微孔间隔光栅周期。

Patent Agency Ranking